Citations (253)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
Hajime Kato, Hiroyasu Sato, Michiaki Okuda, Jun Wu, Shingo Koyama, Yasuhiko Izumi, Tomonori Waku, Mitsuyoshi Iino, Masashi Aoki, Shigeki Arawaka, Yasuyuki Ohta, Kenichi Ishizawa, Kanan Kawasaki, Yasuomi Urano, Tomohiro Miyasaka, Noriko Noguchi, Toshiaki Kume, Akinori Akaike, Hachiro Sugimoto & Takeo Kato. (2022) Therapeutic effect of a novel curcumin derivative GT863 on a mouse model of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 489-495.
Read now
Read now
Richard Bedlack, Paul Barkhaus, Ben Barnes, Michael Bereman, Tulio Bertorini, Gregory Carter, Jesse Crayle, Sky Kihuwa-Mani, Robert Bowser, Pamela Kittrell, Christopher McDermott, Gary Pattee, Kristiana Salmon & Paul Wicks. (2022) ALSUntangled #60: light therapy. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:3-4, pages 315-319.
Read now
Read now
. (2020) ALSUntangled 53: Carnitine supplements. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 477-483.
Read now
Read now
. (2020) ALSUntangled No. 52: Glutathione. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 154-157.
Read now
Read now
. (2020) ALSUntangled 51: RCH4. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 150-153.
Read now
Read now
Rick Bedlack. (2019) ALSUntangled 48: Perampanel (Fycompa). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 453-456.
Read now
Read now
Marion C. Hogg, Luise Halang, Ina Woods, Karen S. Coughlan & Jochen H. M. PREHN. (2018) Riluzole does not improve lifespan or motor function in three ALS mouse models. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 438-445.
Read now
Read now
. (2016) ALSUntangled No. 34: GM604. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:7-8, pages 617-621.
Read now
Read now
. (2016) ALS Untangled No.33 Endotherapia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:5-6, pages 461-465.
Read now
Read now
H Blasco, F Patin, CR Andres, P Corcia & PH Gordon. (2016) Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. Expert Opinion on Pharmacotherapy 17:12, pages 1669-1682.
Read now
Read now
. (2016) ALSUntangled No. 31: Protandim. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 154-156.
Read now
Read now
Letizia Mazzini, Angelo Vescovi, Roberto Cantello, Maurizio Gelati & Alessandro Vercelli. (2016) Stem cells therapy for ALS. Expert Opinion on Biological Therapy 16:2, pages 187-199.
Read now
Read now
. (2015) ALSUntangled No. 30: Methylcobalamin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 536-539.
Read now
Read now
. (2015) ALSUntangled No. 29: MitoQ. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:5-6, pages 427-429.
Read now
Read now
. (2015) ALSUntangled No. 28: Acupuncture. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 286-289.
Read now
Read now
. (2015) ALSUntangled No. 27: Precision Stem Cell. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 282-285.
Read now
Read now
. (2015) ALSUntangled: Introducing The Table of Evidence. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:1-2, pages 142-145.
Read now
Read now
Paul Gordon, Philippe Corcia & Vincent Meininger. (2013) New therapy options for amyotrophic lateral sclerosis. Expert Opinion on Pharmacotherapy 14:14, pages 1907-1917.
Read now
Read now
Karen Castillo, Melissa Nassif, Vicente Valenzuela, Fabiola Rojas, Soledad Matus, Gabriela Mercado, Felipe A. Court, Brigitte van Zundert & Claudio Hetz. (2013) Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9:9, pages 1308-1320.
Read now
Read now
Philippe Corcia & Paul H Gordon. (2012) Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole. Therapeutics and Clinical Risk Management 8, pages 359-366.
Read now
Read now
Renzo Mancuso, Sara Oliván, Pilar Mancera, Andrea Pastén-Zamorano, Raquel Manzano, Caty Casas, Rosario Osta & Xavier Navarro. (2012) Effect of genetic background on onset and disease progression in the SOD1-G93A model of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 13:3, pages 302-310.
Read now
Read now
. (2011) ALSUntangled 13: Bee Venom. Amyotrophic Lateral Sclerosis 12:6, pages 471-472.
Read now
Read now
Melinda Paizs, Massimo Tortarolo, Caterina Bendotti, József I. Engelhardt & László Siklós. (2011) Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically. Amyotrophic Lateral Sclerosis 12:5, pages 340-344.
Read now
Read now
Ali Aamer Habib & Hiroshi Mitsumoto. (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opinion on Emerging Drugs 16:3, pages 537-558.
Read now
Read now
Angela Genge, Steven Wainwright & Christine Vande Velde. Amyotrophic lateral sclerosis: exploring pathophysiology in the context of treatment. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-12.
Read now
Read now
Articles from other publishers (228)
Mikito Shimizu, Naoyuki Shiraishi, Satoru Tada, Tsutomu Sasaki, Goichi Beck, Seiichi NaganoMakoto KinoshitaHisae Sumi, Tomoyuki SugimotoYoko Ishida, Toru Koda, Teruyuki IshikuraYasuko SugiyamaKeigo KiharaMinami Kanakura, Tsuneo Nakajima, Shuko TakedaMasanori P. Takahashi, Toshihide Yamashita, Tatsusada Okuno & Hideki Mochizuki. (2023) RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS. Science Advances 9:47.
Crossref
Crossref
Jingshu Tang, Yuying Kang, Yujun Zhou, Qiuyu Chen, Jiaqi Lan, Xuebin Liu & Ying Peng. (2023) Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models. Brain Research Bulletin 202, pages 110760.
Crossref
Crossref
Sara Hernández, Sara Salvany, Anna Casanovas, Lídia Piedrafita, M. Clara Soto-Bernardini, Olga Tarabal, Alba Blasco, Sílvia Gras, Alaó Gatius, Markus H. Schwab, Jordi Calderó & Josep E. Esquerda. (2023) Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1G93A Mice. Neurotherapeutics 20:6, pages 1820-1834.
Crossref
Crossref
Masaaki Yoshikawa, Mutsumi Matsukawa, Hideki Oshima, Chihiro Ishikawa, Haiyan Li, Takashi Kudo, Dai Shiba, Masaki Shirakawa, Masafumi Muratani, Satoru Takahashi, Mamoru Uemura, Shin Aizawa & Takashi Shiga. (2023) Comparing the effects of microgravity and amyotrophic lateral sclerosis on mouse dorsal root ganglia. Frontiers in Space Technologies 4.
Crossref
Crossref
Ronald Sluyter, Sahil Adriouch, Stephen J. Fuller, Annette Nicke, Reece A. Sophocleous & Debbie Watson. (2023) Animal Models for the Investigation of P2X7 Receptors. International Journal of Molecular Sciences 24:9, pages 8225.
Crossref
Crossref
Christopher Q. Rogers, Melissa Ramirez, Carol S. Landon, Janine M. DeBlasi, Andrew P. Koutnik, Csilla Ari & Dominic P. D’Agostino. (2023) A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS. Nutrients 15:8, pages 1821.
Crossref
Crossref
Tariq Afroz, Elodie Chevalier, Mickael Audrain, Christopher Dumayne, Tamar Ziehm, Roger Moser, Anne-Laure Egesipe, Lorène Mottier, Monisha Ratnam, Manuela Neumann, Daniel Havas, Romain Ollier, Kasia Piorkowska, Mayank Chauhan, Alberto B. Silva, Samjhana Thapa, Jan Stöhr, Andrej Bavdek, Valerie Eligert, Oskar Adolfsson, Peter T. Nelson, Sílvia Porta, Virginia M.-Y. Lee, Andrea Pfeifer, Marie Kosco-Vilbois & Tamara Seredenina. (2023) Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD. Neurobiology of Disease 179, pages 106050.
Crossref
Crossref
Richard J. Mead, Ning Shan, H. Joseph Reiser, Fiona Marshall & Pamela J. Shaw. (2022) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nature Reviews Drug Discovery 22:3, pages 185-212.
Crossref
Crossref
Sophie K. Piper, Dario Zocholl, Ulf Toelch, Robert Roehle, Andrea Stroux, Johanna Hoessler, Anne Zinke & Frank Konietschke. (2022) Statistical review of animal trials—A guideline. Biometrical Journal 65:2.
Crossref
Crossref
Kah Hui Yap, Shahrul Azmin, Suzana Makpol, HanafiAhmad Damanhuri, Muzaimi Mustapha, JemaimaChe Hamzah & NorlinahMohamed Ibrahim. (2023) Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review. Neural Regeneration Research 18:6, pages 1179.
Crossref
Crossref
Dimitrios Tsitsipatis, Krystyna Mazan-Mamczarz, Ying Si, Allison B. Herman, Jen-Hao Yang, Abhishek Guha, Yulan Piao, Jinshui Fan, Jennifer L. Martindale, Rachel Munk, Xiaoling Yang, Supriyo De, Brijesh K. Singh, Ritchie Ho, Myriam Gorospe & Peter H. King. (2022) Transcriptomic analysis of human ALS skeletal muscle reveals a disease-specific pattern of dysregulated circRNAs. Aging 14:24, pages 9832-9859.
Crossref
Crossref
Ang Li, Jianxun Yi, Xuejun Li, Li Dong, Lyle W. Ostrow, Jianjie Ma & Jingsong Zhou. (2022) Deficient Sarcolemma Repair in ALS: A Novel Mechanism with Therapeutic Potential. Cells 11:20, pages 3263.
Crossref
Crossref
Jessica M. Collins, Rachel A.K. Atkinson, Lyzette M. Matthews, Isabella C. Murray, Sharn E. Perry & Anna E. King. (2022) Sarm1 knockout modifies biomarkers of neurodegeneration and spinal cord circuitry but not disease progression in the mSOD1 mouse model of ALS. Neurobiology of Disease 172, pages 105821.
Crossref
Crossref
Maria Chiara Trolese, Carlotta Scarpa, Valentina Melfi, Paola Fabbrizio, Francesca Sironi, Martina Rossi, Caterina Bendotti & Giovanni Nardo. (2022) Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice. Molecular Therapy 30:8, pages 2760-2784.
Crossref
Crossref
Masaaki Yoshikawa, Shin Aizawa, Ronald W. Oppenheim & Carol Milligan. (2022) Neurovascular unit pathology is observed very early in disease progression in the mutant SOD1G93A mouse model of amyotrophic lateral sclerosis. Experimental Neurology 353, pages 114084.
Crossref
Crossref
Matteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano & Giulia Caron. (2022) AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin. Drug Discovery Today 27:6, pages 1652-1660.
Crossref
Crossref
Michael Bette, Eileen Cors, Carolin Kresse & Burkhard Schütz. (2022) Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes. International Journal of Molecular Sciences 23:6, pages 3403.
Crossref
Crossref
Xuejun Li, Li Dong, Ang Li, Jianxun Yi, Marco Brotto & Jingsong Zhou. (2022) Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS. Biomolecules 12:2, pages 333.
Crossref
Crossref
Nancy Tarantino, Ileana Canfora, Giulia Maria Camerino & Sabata Pierno. (2022) Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle. Cells 11:3, pages 415.
Crossref
Crossref
Flore Gouel, Kelly Timmerman, Philippe Gosset, Cedric Raoul, Mary Dutheil, Aurélie Jonneaux, Guillaume Garçon, Caroline Moreau, Veronique Danel-Brunaud, James Duce, Thierry Burnouf, Jean-Christophe Devedjian & David Devos. (2022) Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis. Biomaterials 280, pages 121311.
Crossref
Crossref
Paola Fabbrizio, Jessica D’Agostino, Cassandra Margotta, Giulia Mella, Nicolò Panini, Laura Pasetto, Eliana Sammali, Flavia Raggi, Gianni Sorarù, Valentina Bonetto, Caterina Bendotti & Giovanni Nardo. (2021) Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice. Cellular and Molecular Life Sciences 79:1.
Crossref
Crossref
Pablo Rozas, Cristina Pinto, Francisca Martínez Traub, Rodrigo Díaz, Viviana Pérez, Daniela Becerra, Patricia Ojeda, Jorge Ojeda, Madison T. Wright, Jessica Mella, Lars Plate, Juan Pablo Henríquez, Claudio Hetz & Danilo B. Medinas. (2021) Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALS. Acta Neuropathologica Communications 9:1.
Crossref
Crossref
Hojae Lee, Jae Jin Lee, Na Young Park, Sandeep Kumar Dubey, Taeyong Kim, Kai Ruan, Su Bin Lim, Seong-Hyun Park, Shinwon Ha, Irina Kovlyagina, Kyung-tai Kim, Seongjun Kim, Yohan Oh, Hyesoo Kim, Sung-Ung Kang, Mi-Ryoung Song, Thomas E. Lloyd, Nicholas J. Maragakis, Young Bin Hong, Hyungjin Eoh & Gabsang Lee. (2021) Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nature Neuroscience 24:12, pages 1673-1685.
Crossref
Crossref
Nuno Jorge Lamas & Laurent Roybon. (2021) Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient. Frontiers in Drug Discovery 1.
Crossref
Crossref
Isabella Orienti, Monica Armida, Gabriella Dobrowolny, Rita Pepponi, Gabriella Sollazzini, Antonella Pezzola, Irene Casola, Antonio Musarò, Patrizia Popoli & Rosa Luisa Potenza. (2021) Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences. Neuroscience 473, pages 1-12.
Crossref
Crossref
Phan H. Truong, Peter J. Crouch, James B. W. Hilton, Catriona A. McLean, Roberto Cappai & Giuseppe D. Ciccotosto. (2021) Sex-dependent effects of amyloid precursor-like protein 2 in the SOD1-G37R transgenic mouse model of MND. Cellular and Molecular Life Sciences 78:19-20, pages 6605-6630.
Crossref
Crossref
Jianxun Yi, Ang Li, Xuejun Li, Kiho Park, Xinyu Zhou, Frank Yi, Yajuan Xiao, Dosuk Yoon, Tao Tan, Lyle W. Ostrow, Jianjie Ma & Jingsong Zhou. (2021) MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression. Antioxidants 10:10, pages 1522.
Crossref
Crossref
Amanda L. Wright, Paul A. Della Gatta, Sheng Le, Britt A. Berning, Prachi Mehta, Kelly R. Jacobs, Hossai Gul, Rebecca San Gil, Thomas J. Hedl, Winonah R. Riddell, Owen Watson, Sean S. Keating, Juliana Venturato, Roger S. Chung, Julie D. Atkin, Albert Lee, Bingyang Shi, Catherine A. Blizzard, Marco Morsch & Adam K. Walker. (2021) Riluzole does not ameliorate disease caused by cytoplasmic TDP‐43 in a mouse model of amyotrophic lateral sclerosis. European Journal of Neuroscience 54:6, pages 6237-6255.
Crossref
Crossref
Amy Keerie, Heledd Brown-Wright, Isaac Kirkland, Andrew Grierson, James J. P. Alix, Christian Holscher & Richard J. Mead. (2021) The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS. Scientific Reports 11:1.
Crossref
Crossref
Shyuan T. Ngo, Hao Wang, Robert D. Henderson, Cyril Bowers & Frederik J. Steyn. (2021) Ghrelin as a treatment for amyotrophic lateral sclerosis. Journal of Neuroendocrinology 33:7.
Crossref
Crossref
Yuri Ciervo, Noemi Gatto, Chloe Allen, Andrew Grierson, Laura Ferraiuolo, Richard J. Mead & Pamela J. Shaw. (2021) Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS. Molecular Therapy - Methods & Clinical Development 21, pages 413-433.
Crossref
Crossref
Sudheer K. Tungtur, Heather M. Wilkins, Robert S. Rogers, Yomna Badawi, Jessica M. Sage, Abdulbaki Agbas, Omar Jawdat, Richard J. Barohn, Russell H. Swerdlow & Hiroshi Nishimune. (2021) Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord. Scientific Reports 11:1.
Crossref
Crossref
Lei Zhu, Fan Hu, Cheng Li, Caixiang Zhang, Ruiwen Hang & Renshi Xu. (2020) Perilipin 4 Protein: an Impending Target for Amyotrophic Lateral Sclerosis. Molecular Neurobiology 58:4, pages 1723-1737.
Crossref
Crossref
Mireia Herrando‐Grabulosa, Núria Gaja‐Capdevila, José M. Vela & Xavier Navarro. (2020) Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis. British Journal of Pharmacology 178:6, pages 1336-1352.
Crossref
Crossref
Maria Chiara Trolese, Alessandro Mariani, Mineko Terao, Massimiliano de Paola, Paola Fabbrizio, Francesca Sironi, Mami Kurosaki, Silvia Bonanno, Stefania Marcuzzo, Pia Bernasconi, Francesca Trojsi, Eleonora Aronica, Caterina Bendotti & Giovanni Nardo. (2020) CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis. eBioMedicine 62, pages 103097.
Crossref
Crossref
Byung Woo Kim, Jiwon Ryu, Ye Eun Jeong, Juhyun Kim & Lee J. Martin. (2020) Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Teresa Cunha-Oliveira, Liliana Montezinho, Catarina Mendes, Omidreza Firuzi, Luciano Saso, Paulo J. Oliveira & Filomena S. G. Silva. (2020) Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity 2020, pages 1-29.
Crossref
Crossref
Sara Nikseresht, James B.W. Hilton, Kai Kysenius, Jeffrey R. Liddell & Peter J. Crouch. (2020) Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond. Life 10:11, pages 271.
Crossref
Crossref
Cristina Ruiz-Ruiz, Nuria García-Magro, Pilar Negredo, Carlos Avendaño, Anindya Bhattacharya, Marc Ceusters & Antonio G. García. (2020) Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1G93A female mice. Disease Models & Mechanisms 13:10.
Crossref
Crossref
Sara L. Dominguez, Timothy Earr, Michelle Dourado, Hai Ngu, William J. Meilandt & Jesse E. Hanson. (2020) Inducible EphA4 knockout causes motor deficits in young mice and is not protective in the SOD1G93A mouse model of ALS. Scientific Reports 10:1.
Crossref
Crossref
Tsukasa Shimauchi, François Potus, Sébastien Bonnet, Steeve Provencher, Roxane Paulin & Olivier Boucherat. (2020) Limitations and Flaws of Preclinical Pulmonary Hypertension Studies. Advances in Pulmonary Hypertension 19:2, pages 47-54.
Crossref
Crossref
Yu Zhu, Yue Liu, Fang Yang, Wenzhi Chen, Jianxian Jiang, Pei He, Shishi Jiang, Menhua Li & Renshi Xu. (2020) All-Trans Retinoic Acid Exerts Neuroprotective Effects in Amyotrophic Lateral Sclerosis-Like Tg (SOD1*G93A)1Gur Mice. Molecular Neurobiology 57:8, pages 3603-3615.
Crossref
Crossref
Liping Liu, Kelby M. Killoy, Marcelo R. Vargas, Yasuhiko Yamamoto & Mariana Pehar. (2020)
Effects of RAGE inhibition on the progression of the disease in hSOD1
G93A
ALS mice
. Pharmacology Research & Perspectives 8:4.
Crossref
Crossref
Sudhanshu Raj & Navpreet Kaur Walia. (2020) A Study on Metasploit Framework: A Pen-Testing Tool. A Study on Metasploit Framework: A Pen-Testing Tool.
Anna Kiryk, Artur Janusz, Bartosz Zglinicki, Emir Turkes, Ewelina Knapska, Witold Konopka, Hans-Peter Lipp & Leszek Kaczmarek. (2020) IntelliCage as a tool for measuring mouse behavior – 20 years perspective. Behavioural Brain Research 388, pages 112620.
Crossref
Crossref
Johannes P.J.M. de Munter, Igor Shafarevich, Alexei Liundup, Dmitrii Pavlov, Erik Ch Wolters, Anna Gorlova, Ekaterina Veniaminova, Aleksei Umriukhin, Allan Kalueff, Andrei Svistunov, Boris W. Kramer, Klaus‐Peter Lesch & Tatyana Strekalova. (2019) Neuro‐Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice. CNS Neuroscience & Therapeutics 26:5, pages 504-517.
Crossref
Crossref
Jan Vollert, Esther Schenker, Malcolm Macleod, Anton Bespalov, Hanno Wuerbel, Martin Michel, Ulrich Dirnagl, Heidrun Potschka, Ann-Marie Waldron, Kimberley Wever, Thomas Steckler, Tom van de Casteele, Bruce Altevogt, Annesha Sil & Andrew S C Rice. (2020) Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals. BMJ Open Science 4:1, pages e100046.
Crossref
Crossref
Jochen H M Prehn & Elisabeth Jirström. (2020) Angiogenin and tRNA fragments in Parkinson’s disease and neurodegeneration. Acta Pharmacologica Sinica 41:4, pages 442-446.
Crossref
Crossref
Diane Ly, Anjila Dongol, Peter Cuthbertson, Thomas V. Guy, Nicholas J. Geraghty, Reece A. Sophocleous, Lucia Sin, Bradley J. Turner, Debbie Watson, Justin J. Yerbury & Ronald Sluyter. (2020) The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice. Purinergic Signalling 16:1, pages 109-122.
Crossref
Crossref
Tereza Filipi, Zuzana Hermanova, Jana Tureckova, Ondrej Vanatko & Miroslava Anderova. (2020) Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. Journal of Clinical Medicine 9:1, pages 261.
Crossref
Crossref
Benedetta Perrone, Valentina La Cognata, Teresa Sprovieri, Carmine Ungaro, Francesca Luisa Conforti, Sebastiano Andò & Sebastiano Cavallaro. (2019) Alternative Splicing of ALS Genes: Misregulation and Potential Therapies. Cellular and Molecular Neurobiology 40:1, pages 1-14.
Crossref
Crossref
Gabriel N. Valbuena, Lavinia Cantoni, Massimo Tortarolo, Caterina Bendotti & Hector C. Keun. (2019) Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1G93A Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 13.
Crossref
Crossref
Laura Rué, Patrick Oeckl, Mieke Timmers, Annette Lenaerts, Jasmijn van der Vos, Silke Smolders, Lindsay Poppe, Antina de Boer, Ludo Van Den Bosch, Philip Van Damme, Jochen H. Weishaupt, Albert C. Ludolph, Markus Otto, Wim Robberecht & Robin Lemmens. (2019) Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis. Acta Neuropathologica Communications 7:1.
Crossref
Crossref
Laura Rué, Mieke Timmers, Annette Lenaerts, Silke Smolders, Lindsay Poppe, Antina de Boer, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht & Robin Lemmens. (2019) Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis. Scientific Reports 9:1.
Crossref
Crossref
Abhijeet R. Joshi, Ines Muke, Ilja Bobylev & Helmar C. Lehmann. (2019) ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis. Journal of Comparative Neurology 527:14, pages 2334-2340.
Crossref
Crossref
Elisa Lepore, Irene Casola, Gabriella Dobrowolny & Antonio Musarò. (2019) Neuromuscular Junction as an Entity of Nerve-Muscle Communication. Cells 8:8, pages 906.
Crossref
Crossref
Joana G Fernandes, Nuno H Franco, Andrew J Grierson, Jan Hultgren, Andrew J W Furley & I Anna S Olsson. (2019) Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review. BMJ Open Science 3:1, pages e000016.
Crossref
Crossref
Savina Apolloni, Susanna Amadio, Paola Fabbrizio, Giovanna Morello, Antonio Gianmaria Spampinato, Emanuele Claudio Latagliata, Illari Salvatori, Daisy Proietti, Alberto Ferri, Luca Madaro, Stefano Puglisi‐Allegra, Sebastiano Cavallaro & Cinzia Volonté. (2019) Histaminergic transmission slows progression of amyotrophic lateral sclerosis. Journal of Cachexia, Sarcopenia and Muscle 10:4, pages 872-893.
Crossref
Crossref
Amanda MacPherson & Jonathan Kimmelman. (2019) Ethical development of stem-cell-based interventions. Nature Medicine 25:7, pages 1037-1044.
Crossref
Crossref
Atsushi Sawada, Shanshan Wang, Minyu Jian, Joseph Leem, Jesse Wackerbarth, Junji Egawa, Jan M. Schilling, Oleksandr Platoshyn, Alice Zemljic-Harpf, David M. Roth, Hemal H. Patel, Piyush M. Patel, Martin Marsala & Brian P. Head. (2019)
Neuron‐targeted caveolin‐1 improves neuromuscular function and extends survival in SOD1
G93A
mice
. The FASEB Journal 33:6, pages 7545-7554.
Crossref
Crossref
Monica Armida, Alessandra Matteucci, Antonella Pèzzola, Younis Baqi, Christa E. Müller, Patrizia Popoli & Rosa Luisa Potenza. (2019) Modulating P1 Adenosine Receptors in Disease Progression of SOD1G93A Mutant Mice. Neurochemical Research 44:5, pages 1037-1042.
Crossref
Crossref
Martin Crivello, Marion C. Hogg, Elisabeth Jirström, Luise Halang, Ina Woods, Megan Rayner, Karen S. Coughlan, Sebastian L. Lewandowski & Jochen H. M. Prehn. (2019) Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model. Disease Models & Mechanisms.
Crossref
Crossref
Arpan R Mehta, Rachel Walters, Fergal M Waldron, Suvankar Pal, Bhuvaneish T Selvaraj, Malcolm R Macleod, Giles E Hardingham, Siddharthan Chandran & Jenna M Gregory. (2019) Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Brain Communications 1:1.
Crossref
Crossref
Muhibullah S. Tora, Kelly M. Poth, Nathan Hardcastle, Kaitlin Sandor, Casey Anthony, Long Di & Nicholas M. Boulis. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
133
161
.
Diane T. Stephenson & Stephen P. Arnerić. 2019. Translational Medicine in CNS Drug Development. Translational Medicine in CNS Drug Development
277
296
.
Mukesh Gautam, Javier H. Jara, Nuran Kocak, Lauren E. Rylaarsdam, Ki Dong Kim, Eileen H. Bigio & P. Hande Özdinler. (2018) Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathologica 137:1, pages 47-69.
Crossref
Crossref
Amaya Rando, Diego Pastor, Mari Carmen Viso-León, Anna Martínez, Raquel Manzano, Xavier Navarro, Rosario Osta & Salvador Martínez. (2018) Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease. Stem Cell Research & Therapy 9:1.
Crossref
Crossref
Giovanni Nardo, Maria Chiara Trolese, Mattia Verderio, Alessandro Mariani, Massimiliano de Paola, Nilo Riva, Giorgia Dina, Nicolò Panini, Eugenio Erba, Angelo Quattrini & Caterina Bendotti. (2018) Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Holger Langhof, William Wei Lim Chin, Susanne Wieschowski, Carole Federico, Jonathan Kimmelman & Daniel Strech. (2018) Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross‐sectional study. British Journal of Pharmacology 175:22, pages 4229-4238.
Crossref
Crossref
Ted M. Dawson, Todd E. Golde & Clotilde Lagier-Tourenne. (2018) Animal models of neurodegenerative diseases. Nature Neuroscience 21:10, pages 1370-1379.
Crossref
Crossref
Germana Cocozza, Maria Amalia di Castro, Laura Carbonari, Alfonso Grimaldi, Fabrizio Antonangeli, Stefano Garofalo, Alessandra Porzia, Michele Madonna, Fabrizio Mainiero, Angela Santoni, Francesca Grassi, Heike Wulff, Giuseppina D'Alessandro & Cristina Limatola. (2018) Ca2+-activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice. Brain, Behavior, and Immunity 73, pages 584-595.
Crossref
Crossref
Lorenzo Schiaffino, Roberta Bonafede, Ilaria Scambi, Edoardo Parrella, Marina Pizzi & Raffaella Mariotti. (2018) Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model. Scientific Reports 8:1.
Crossref
Crossref
Cathleen Lutz. (2018) Mouse models of ALS: Past, present and future. Brain Research 1693, pages 1-10.
Crossref
Crossref
Patrizia Bossolasco, Francesca Sassone, Valentina Gumina, Silvia Peverelli, Maria Garzo & Vincenzo Silani. (2018) Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient. Stem Cell Research 30, pages 61-68.
Crossref
Crossref
HaoJie Hu, HuiQian Lin, WeiSong Duan, Can Cui, ZhongYao Li, YaKun Liu, Wan Wang, Di Wen, Ying Wang & ChunYan Li. (2018) Intrathecal Injection of scAAV9–hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway. Neuroscience 381, pages 1-10.
Crossref
Crossref
Vivian Leung, Frédérik Rousseau-Blass, Guy Beauchamp & Daniel S. J. Pang. (2018) ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia. PLOS ONE 13:5, pages e0197882.
Crossref
Crossref
Martin Crivello, Saidhbhe L. O'Riordan, Ina Woods, Sarah Cannon, Luise Halang, Karen S. Coughlan, Marion C. Hogg, Sebastian A. Lewandowski & Jochen H.M. Prehn. (2018) Pleiotropic activity of systemically delivered angiogenin in the SOD1G93A mouse model. Neuropharmacology 133, pages 503-511.
Crossref
Crossref
Stephen P. Arnerić, Volker D. Kern & Diane T. Stephenson. (2018) Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments. Biochemical Pharmacology 151, pages 291-306.
Crossref
Crossref
Andrés Trostchansky, Mauricio Mastrogiovanni, Ernesto Miquel, Sebastián Rodríguez-Bottero, Laura Martínez-Palma, Patricia Cassina & Homero Rubbo. (2018) Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Martina NaselloGiuseppe SchiròFloriana CrapanzanoCarmela Rita Balistreri. (2018) Stem Cells and Other Emerging Agents as Innovative “Drugs” in Neurodegenerative Diseases: Benefits and Limitations. Rejuvenation Research 21:2, pages 123-140.
Crossref
Crossref
Brett M. Hewitt, Moi Hoon Yap, Emma F. Hodson-Tole, Aneurin J. Kennerley, Paul S. Sharp & Robyn A. Grant. (2018) A novel automated rodent tracker (ART), demonstrated in a mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience Methods 300, pages 147-156.
Crossref
Crossref
Steeve ProvencherStephen L. ArcherF. Daniel RamirezBenjamin HibbertRoxane PaulinOlivier BoucheratYves LacasseSébastien Bonnet. (2018) Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research. Circulation Research 122:7, pages 1021-1032.
Crossref
Crossref
Jianguo Liu, Elise Allender, Jiajing Wang, Eleanor H. Simpson, Jeffrey A. Loeb & Fei Song. (2018) Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation. Neurobiology of Disease 111, pages 118-126.
Crossref
Crossref
Ina Dervishi & P. Hande Ozdinler. (2018) Incorporating upper motor neuron health in ALS drug discovery. Drug Discovery Today 23:3, pages 696-703.
Crossref
Crossref
Raffaella Willmann, Filippo Buccella, Annamaria De Luca, Miranda D. Grounds, Jenny Versnel, Elizabeth Vroom, Diana Ribeiro, Anna Ambrosini, Grace Pavlath, John Porter, Gustavo Dziewczapolski, Victor Dubowitz, Hanns Lochmüller, Kevin Campbell, Kay Davies, Kevin A. Roth, Alejandra Clark, Emilio Clementi, Kanneboyina Nagaraju, Nathalie Goemans, Volker Straub, Andrea Klein, Annemieke Aartsma-Rus, Miranda Grounds, Raffaella Willmann, Filippo Buccella, Maaike van Putten, Maria Fries, Maria Sheean, Jon Tinsley & Mahasweta Girgenrath. (2018) 227 th ENMC International Workshop:. Neuromuscular Disorders 28:2, pages 185-192.
Crossref
Crossref
Alexandre Henriques, Vincent Croixmarie, Alexandra Bouscary, Althéa Mosbach, Céline Keime, Claire Boursier-Neyret, Bernard Walter, Michael Spedding & Jean-Philippe Loeffler. (2018) Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
JessicaR Morrice, CherylY Gregory-Evans & ChristopherA Shaw. (2018) Animal models of amyotrophic lateral sclerosis: A comparison of model validity. Neural Regeneration Research 13:12, pages 2050.
Crossref
Crossref
Maria E. Sheean, Violeta Stoyanova-Beninska, Giuseppe Capovilla, Dinah Duarte, Matthias P. Hofer, Michel Hoffmann, Armando Magrelli, Segundo Mariz, Stelios Tsigkos, Evyenia Shaili, Benedetta Polsinelli, Mario Ricciardi, Milton Bonelli, Pavel Balabanov, Kristina Larsson & Bruno Sepodes. (2018) Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions. Drug Discovery Today 23:1, pages 26-48.
Crossref
Crossref
Basant Amarji, Sara Nidal Abed, Ujjawal Bairagi, Pran Kishore Deb, Omar Al-Attraqchi, Anup Avijit Choudhury & Rakesh K. Tekade. 2018. Dosage Form Design Considerations. Dosage Form Design Considerations
637
668
.
HuiQian Lin, HaoJie Hu, WeiSong Duan, YaLing Liu, GuoJun Tan, ZhongYao Li, YaKun Liu, BinBin Deng, XueQin Song, Wan Wang, Di Wen, Ying Wang & ChunYan Li. (2016) Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1G93A ALS Mouse Model via Upregulation of D-Amino Acid Oxidase. Molecular Neurobiology 55:1, pages 682-695.
Crossref
Crossref
Andrew P. Tosolini & James N. Sleigh. (2017) Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Xiao Hu, James P. Charles, Turgay Akay, John R. Hutchinson & Silvia S. Blemker. (2017) Are mice good models for human neuromuscular disease? Comparing muscle excursions in walking between mice and humans. Skeletal Muscle 7:1.
Crossref
Crossref
Helena Röcklinsberg, Mickey Gjerris & I Anna S. OlssonKatarina Cvek, Orsolya E. Varga, Catherine Schuppli, Elisabeth Ormandy, Javier Guillén, Franz Gruber & Joana Fernandes. 2017. Animal Ethics in Animal Research. Animal Ethics in Animal Research.
Nakul Katyal & Raghav Govindarajan. (2017) Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement. Frontiers in Neurology 8.
Crossref
Crossref
Albert Ludolph. (2017) Edaravone: a baby in the bathwater?. Therapeutic Advances in Neurological Disorders 10:9, pages 313-314.
Crossref
Crossref
Noemi Pasquarelli, Michael Engelskirchen, Johannes Hanselmann, Sascha Endres, Christoph Porazik, Hanna Bayer, Eva Buck, Meliha Karsak, Patrick Weydt, Boris Ferger & Anke Witting. (2017) Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS. Neuropharmacology 124, pages 157-169.
Crossref
Crossref
Paola Fabbrizio, Susanna Amadio, Savina Apolloni & Cinzia Volonté. (2017) P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia. Frontiers in Cellular Neuroscience 11.
Crossref
Crossref
Sadanori Miyoshi, Tohru Tezuka, Sumimasa Arimura, Taro Tomono, Takashi Okada & Yuji Yamanashi. (2017)
DOK
7
gene therapy enhances motor activity and life span in
ALS
model mice
. EMBO Molecular Medicine 9:7, pages 880-889.
Crossref
Crossref
Laura M Luh, Indrajit Das & Anne Bertolotti. (2016) qMotor, a set of rules for sensitive, robust and quantitative measurement of motor performance in mice. Nature Protocols 12:7, pages 1451-1457.
Crossref
Crossref
Eva Kichkin, Archunan Visvanathan, Frank J. Lovicu, Daisy Y. Shu, Shannon J. Das, Stephen W. Reddel, Emily P. McCann, Katharine Y. Zhang, Kelly L. Williams, Ian P. Blair & William D. Phillips. (2017) Postnatal Development of Spasticity Following Transgene Insertion in the Mouse βIV Spectrin Gene (SPTBN4). Journal of Neuromuscular Diseases 4:2, pages 159-164.
Crossref
Crossref
MelissaM Haulcomb, RenaM Meadows, WhitneyM Miller, KathrynP McMillan, MeKenzieJ Hilsmeyer, Xuefu Wang, WesleyT Beaulieu, StephanieL Dickinson, ToddJ Brown, VirginiaM Sanders & KathrynJ Jones. (2017) Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis. Neural Regeneration Research 12:10, pages 1664.
Crossref
Crossref
S. Shekar Dukkipati, Aouatef Chihi, Yiwen Wang & Sherif M. Elbasiouny. (2017) Experimental Design and Data Analysis Issues Contribute to Inconsistent Results of C-Bouton Changes in Amyotrophic Lateral Sclerosis. eneuro 4:1, pages ENEURO.0281-16.2016.
Crossref
Crossref
Amaya Rando, Samanta Gasco, Miriam de la Torre, Alberto García-Redondo, Pilar Zaragoza, Janne M. Toivonen & Rosario Osta. (2017) Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitro. Neurodegenerative Diseases 17:1, pages 1-13.
Crossref
Crossref
Alexander McGown, Dame Pamela J. Shaw & Tennore Ramesh. (2016) ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis. Molecular Neurodegeneration 11:1.
Crossref
Crossref
Savina Apolloni, Paola Fabbrizio, Susanna Amadio & Cinzia Volonté. (2016) Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression. Journal of Neuroinflammation 13:1.
Crossref
Crossref
Samanta Gasco, Amaya Rando, Pilar Zaragoza, Alberto García-Redondo, Ana Cristina Calvo & Rosario Osta. (2016) Hematopoietic stem and progenitor cells as novel prognostic biomarkers of longevity in a murine model for amyotrophic lateral sclerosis. American Journal of Physiology-Cell Physiology 311:6, pages C910-C919.
Crossref
Crossref
William DeCoteau, Karin L. Heckman, Ana Y. Estevez, Kenneth J. Reed, Wendi Costanzo, David Sandford, Paige Studlack, Jennifer Clauss, Elizabeth Nichols, Jennifer Lipps, Matthew Parker, Bonnie Hays-Erlichman, J.C. Leiter & Joseph S. Erlichman. (2016) Cerium oxide nanoparticles with antioxidant properties ameliorate strength and prolong life in mouse model of amyotrophic lateral sclerosis. Nanomedicine: Nanotechnology, Biology and Medicine 12:8, pages 2311-2320.
Crossref
Crossref
Kelly E. Glajch, Laura Ferraiuolo, Kaly A. Mueller, Matthew J. Stopford, Varsha Prabhkar, Achille Gravanis, Pamela J. Shaw & Ghazaleh Sadri-Vakili. (2016) MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis. PLOS ONE 11:10, pages e0164103.
Crossref
Crossref
Jörg B. Schulz, Mark R. Cookson & Laura Hausmann. (2016) The impact of fraudulent and irreproducible data to the translational research crisis – solutions and implementation. Journal of Neurochemistry 139:S2, pages 253-270.
Crossref
Crossref
Gianina Teribele Venturin, Samuel Greggio, Gabriele Zanirati, Daniel Rodrigo Marinowic, Iuri Marques de Oliveira, João Antonio Pêgas Henriques & Jaderson Costa DaCosta. (2016) Transplantation of bone marrow mononuclear cells prolongs survival, delays disease onset and progression and mitigates neuronal loss in pre-symptomatic, but not symptomatic ALS mice. Neuroscience Letters 633, pages 182-188.
Crossref
Crossref
Rosa Luisa Potenza, Roberta De Simone, Monica Armida, Valentina Mazziotti, Antonella Pèzzola, Patrizia Popoli & Luisa Minghetti. (2016) Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics 13:4, pages 918-927.
Crossref
Crossref
Tesfaye W. Tefera, Yide Wong, Mallory E. Barkl-Luke, Shyuan T. Ngo, Nicola K. Thomas, Tanya S. McDonald & Karin Borges. (2016) Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis. PLOS ONE 11:8, pages e0161816.
Crossref
Crossref
Tamara Seredenina, Zeynab Nayernia, Silvia Sorce, Ghassan J. Maghzal, Aleksandra Filippova, Shuo-Chien Ling, Olivier Basset, Olivier Plastre, Youssef Daali, Elisabeth J. Rushing, Maria T. Giordana, Don W. Cleveland, Adriano Aguzzi, Roland Stocker, Karl-Heinz Krause & Vincent Jaquet. (2016) Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis. Free Radical Biology and Medicine 97, pages 95-108.
Crossref
Crossref
Marianne I. Martic-Kehl & P. August Schubiger. 2016. Reproducibility: Principles, Problems, Practices, and Prospects. Reproducibility: Principles, Problems, Practices, and Prospects
291
314
.
S. Gargiulo, S. Anzilotti, A. R. D. Coda, M. Gramanzini, A. Greco, M. Panico, A. Vinciguerra, A. Zannetti, C. Vicidomini, F. Dollé, G. Pignataro, M. Quarantelli, L. Annunziato, A. Brunetti, M. Salvatore & S. Pappatà. (2016) Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 43:7, pages 1348-1359.
Crossref
Crossref
Hongjie Wang, Ruizhi Wang, Shaohua Xu & Madepalli K. Lakshmana. (2016) Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer’s and Amyotrophic Lateral Sclerosis Brains. Neuroscience Journal 2016, pages 1-8.
Crossref
Crossref
Pascaline Clerc, Scott Lipnick & Catherine Willett. (2016) A look into the future of ALS research. Drug Discovery Today 21:6, pages 939-949.
Crossref
Crossref
Marion C. Hogg, Mollie R. Mitchem, Hans-Georg König & Jochen H.M. Prehn. (2016) Caspase 6 has a protective role in SOD1 G93A transgenic mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:6, pages 1063-1073.
Crossref
Crossref
Fumito Endo, Okiru Komine & Koji Yamanaka. (2016) Neuroinflammation in motor neuron disease. Clinical and Experimental Neuroimmunology 7:2, pages 126-138.
Crossref
Crossref
Conceicao Moura Mirian, Rita Carvalho Garbi Novaes Maria, SSP Zago Yuri, Junio Eduardo Emanoel & Augusto Casulari Luiz. (2016) Efficacy and effectiveness of drug treatments in amyotrophic lateral sclerosis: A systematic review with meta-analysis. African Journal of Pharmacy and Pharmacology 10:13, pages 257-269.
Crossref
Crossref
Hui Qiu, Ji-huang Li, Su-bing Yin, Jiang-qiong Ke, Chang-lin Qiu & Guo-qing Zheng. (2016) Dihuang Yinzi, a Classical Chinese Herbal Prescription, for Amyotrophic Lateral Sclerosis. Medicine 95:14, pages e3324.
Crossref
Crossref
Chantal DarquenneJohn S. FlemingIra KatzAndrew R. MartinJeffry SchroeterOmar S. UsmaniJose VenegasOtmar Schmid. (2016) Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung. Journal of Aerosol Medicine and Pulmonary Drug Delivery 29:2, pages 107-126.
Crossref
Crossref
SungWon Song, Carlos J Miranda, Lyndsey Braun, Kathrin Meyer, Ashley E Frakes, Laura Ferraiuolo, Shibi Likhite, Adam K Bevan, Kevin D Foust, Michael J McConnell, Christopher M Walker & Brian K Kaspar. (2016) Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nature Medicine 22:4, pages 397-403.
Crossref
Crossref
Giovanni Nardo, Maria Chiara Trolese, Massimo Tortarolo, Antonio Vallarola, Mattia Freschi, Laura Pasetto, Valentina Bonetto & Caterina Bendotti. (2016) New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models. Brain Pathology 26:2, pages 237-247.
Crossref
Crossref
Karen S. Coughlan, Luise Halang, Ina Woods & Jochen H. M. Prehn. (2016) A high fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T/ C57BL/6J mice. Disease Models & Mechanisms.
Crossref
Crossref
Savina Apolloni, Paola Fabbrizio, Chiara Parisi, Susanna Amadio & Cinzia Volonté. (2014) Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Molecular Neurobiology 53:1, pages 518-531.
Crossref
Crossref
Anastasios Fotinos, Yongjin Zhu, Lilly L. J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz & Xin Wang. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
869
903
.
Naohide Kondo, Masahisa Katsuno, Yuichi Riku & Gen Sobue. 2016. Heat Shock Factor. Heat Shock Factor
213
242
.
Melissa M. Haulcomb, Nichole A. Mesnard-Hoaglin, Richard J. Batka, Rena M. Meadows, Whitney M. Miller, Kathryn P. Mcmillan, Todd J. Brown, Virginia M. Sanders & Kathryn J. Jones. (2015)
Identification of B6SJL mSOD1
G93A
mouse subgroups with different disease progression rates
. Journal of Comparative Neurology 523:18, pages 2752-2768.
Crossref
Crossref
Richard S. Bedlack, Nanette Joyce, Gregory T. Carter, Sabrina Paganoni & Chafic Karam. (2015) Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 909-936.
Crossref
Crossref
Janessa Chang, Michael Phelan & Brian J. Cummings. (2015) A meta-analysis of efficacy in pre-clinical human stem cell therapies for traumatic brain injury. Experimental Neurology 273, pages 225-233.
Crossref
Crossref
Malcolm R. Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou, Stylianos Serghiou, Arno de Wilde, Nicki Sherratt, Theo Hirst, Rachel Hemblade, Zsanett Bahor, Cristina Nunes-Fonseca, Aparna Potluru, Andrew Thomson, Julija Baginskitae, Kieren Egan, Hanna Vesterinen, Gillian L. Currie, Leonid Churilov, David W. Howells & Emily S. Sena. (2015) Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLOS Biology 13:10, pages e1002273.
Crossref
Crossref
Renzo Mancuso & Xavier Navarro. (2015) Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic. Progress in Neurobiology 133, pages 1-26.
Crossref
Crossref
Emanuele Rizzuto, Simona Pisu, Antonio Musarò & Zaccaria Del Prete. (2015) Measuring Neuromuscular Junction Functionality in the SOD1G93A Animal Model of Amyotrophic Lateral Sclerosis. Annals of Biomedical Engineering 43:9, pages 2196-2206.
Crossref
Crossref
Fernando G. Vieira, Qinggong Ping, Andy J. Moreno, Joshua D. Kidd, Kenneth Thompson, Bingbing Jiang, John M. Lincecum, Monica Z. Wang, Gerard S. De Zutter, Valerie R. Tassinari, Beth Levine, Theo Hatzipetros, Alan Gill & Steven Perrin. (2015) Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS. PLOS ONE 10:8, pages e0135570.
Crossref
Crossref
Yinan Zhang, Kevin Tianmeng Zhao, Susan G. Fox, Jinho Kim, Donald R. Kirsch, Robert J. Ferrante, Richard I. Morimoto & Richard B. Silverman. (2015) Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis. Journal of Medicinal Chemistry 58:15, pages 5942-5949.
Crossref
Crossref
W.D. Phillips, P. Christadoss, M. Losen, A.R. Punga, K. Shigemoto, J. Verschuuren & A. Vincent. (2015) Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis. Experimental Neurology 270, pages 29-40.
Crossref
Crossref
Y. Li, Y. Guo, X. Wang, X. Yu, W. Duan, K. Hong, J. Wang, H. Han & C. Li. (2015) Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience 298, pages 12-25.
Crossref
Crossref
Lavinia Palamiuc, Anna Schlagowski, Shyuan T Ngo, Aurelia Vernay, Sylvie Dirrig‐Grosch, Alexandre Henriques, Anne‐Laurence Boutillier, Joffrey Zoll, Andoni Echaniz‐Laguna, Jean‐Philippe Loeffler & Frédérique René. (2015) A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Molecular Medicine 7:5, pages 526-546.
Crossref
Crossref
Meital Edri-Brami, Hila Sharoni, Dana Hayoun, Linor Skutelsky, Ana Nemirovsky, Angel Porgador & Rachel G. Lichtenstein. (2015) Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals. Experimental Neurology 267, pages 95-106.
Crossref
Crossref
Victoria Hampshire. (2015) A systematic process for physical examination in preclinical research. Lab Animal 44:3, pages 89-90.
Crossref
Crossref
Yuko Kobayakawa, Kunihiko Sakumi, Kosuke Kajitani, Toshihiko Kadoya, Hidenori Horie, Jun-ichi Kira & Yusaku Nakabeppu. (2015)
Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1
G93A
transgenic mice
. Neuropathology and Applied Neurobiology 41:2, pages 227-244.
Crossref
Crossref
Julie A. Kelly, Noreen T. Boyle, Natalie Cole, Gillian R. Slator, M. Alessandra Colivicchi, Chiara Stefanini, Oliviero L. Gobbo, Gaia A. Scalabrino, Sinead M. Ryan, Marwa Elamin, Cathal Walsh, Alice Vajda, Margaret M. Goggin, Matthew Campbell, Deborah C. Mash, Shane M. O'Mara, David J. Brayden, John J. Callanan, Keith F. Tipton, Laura Della Corte, Jackie Hunter, Kathy M. O'Boyle, Carvell H. Williams & Orla Hardiman. (2015) First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Neuropharmacology 89, pages 193-203.
Crossref
Crossref
Karen S. Coughlan, Mollie R. Mitchem, Marion C. Hogg & Jochen H.M. Prehn. (2015) “Preconditioning” with latrepirdine, an adenosine 5′-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1G93A mice. Neurobiology of Aging 36:2, pages 1140-1150.
Crossref
Crossref
Xiqun Chen, Pauline Wales, Luisa Quinti, Fuxing Zuo, Sébastien Moniot, Fanny Herisson, Nazifa Abdul Rauf, Hua Wang, Richard B. Silverman, Cenk Ayata, Michelle M. Maxwell, Clemens Steegborn, Michael A. Schwarzschild, Tiago F. Outeiro & Aleksey G. Kazantsev. (2015) The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia. PLOS ONE 10:1, pages e0116919.
Crossref
Crossref
Sara OLIVÁN, Ana Cristina CALVO, Amaya RANDO, María Jesús MUÑOZ, Pilar ZARAGOZA & Rosario OSTA. (2015) Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Experimental Animals 64:2, pages 147-153.
Crossref
Crossref
A. Y. Estevez, W. E. DeCoteau, K. L. Heckman & J. S. Erlichman. 2015. Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2. Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2
431
461
.
Marianna Marino, Simonetta Papa, Valeria Crippa, Giovanni Nardo, Marco Peviani, Cristina Cheroni, Maria Chiara Trolese, Eliana Lauranzano, Valentina Bonetto, Angelo Poletti, Silvia DeBiasi, Laura Ferraiuolo, Pamela J. Shaw & Caterina Bendotti. (2015) Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis. Neurobiology of Aging 36:1, pages 492-504.
Crossref
Crossref
Yongjin Zhu, Anastasios Fotinos, Lilly L.J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz & Xin Wang. (2015) Neuroprotective agents target molecular mechanisms of disease in ALS. Drug Discovery Today 20:1, pages 65-75.
Crossref
Crossref
Eva de Lago, Miguel Moreno-Martet, Francisco Espejo-Porras & Javier Fernández-Ruiz. 2015. Cannabinoids in Neurologic and Mental Disease. Cannabinoids in Neurologic and Mental Disease
99
123
.
Paul H. Gordon, Kate Dalton & Philippe Corcia. 2015. Diet and Nutrition in Dementia and Cognitive Decline. Diet and Nutrition in Dementia and Cognitive Decline
23
34
.
Jonathan Kimmelman & Spencer Phillips Hey. 2015. Handbook of Neuroethics. Handbook of Neuroethics
1107
1124
.
Fernando G. Vieira, Eva LaDow, Andy Moreno, Joshua D. Kidd, Beth Levine, Kenneth Thompson, Alan Gill, Steven Finkbeiner & Steven Perrin. (2014) Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration. PLoS ONE 9:12, pages e91608.
Crossref
Crossref
Erika Ross, Aimee Winter, Heather Wilkins, Whitney Sumner, Nathan Duval, David Patterson & Daniel Linseman. (2014) A Cystine-Rich Whey Supplement (Immunocal®) Delays Disease Onset and Prevents Spinal Cord Glutathione Depletion in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Antioxidants 3:4, pages 843-865.
Crossref
Crossref
Pierre Zwiegers, Grace Lee & Christopher A Shaw. (2014) Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents. Journal of Negative Results in BioMedicine 13:1.
Crossref
Crossref
Daniel Cacabelos, Victoria Ayala, Omar Ramírez-Nunez, Ana Belen Granado-Serrano, Jordi Boada, Jose C. E. Serrano, Rosanna Cabré, Gisela Nadal-Rey, Maria Josep Bellmunt, Isidro Ferrer, Reinald Pamplona & Manuel Portero-Otin. (2014) Dietary Lipid Unsaturation Influences Survival and Oxidative Modifications of an Amyotrophic Lateral Sclerosis Model in a Gender-Specific Manner. NeuroMolecular Medicine 16:4, pages 669-685.
Crossref
Crossref
Renzo Mancuso, Rosario Osta & Xavier Navarro. (2014)
Presymptomatic electrophysiological tests predict clinical onset and survival in SOD1
G93A
ALS mice
. Muscle & Nerve 50:6, pages 943-949.
Crossref
Crossref
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
Crossref
Theo Hatzipetros, Laurent P. Bogdanik, Valerie R. Tassinari, Joshua D. Kidd, Andy J. Moreno, Crystal Davis, Melissa Osborne, Andrew Austin, Fernando G. Vieira, Cathleen Lutz & Steve Perrin. (2014) C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Research 1584, pages 59-72.
Crossref
Crossref
Ellen J. Bennett, Richard J. Mead, Mimoun Azzouz, Pamela J. Shaw & Andrew J. Grierson. (2014) Early Detection of Motor Dysfunction in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Using Home Cage Running Wheels. PLoS ONE 9:9, pages e107918.
Crossref
Crossref
F. Josef van der Staay, Saskia S. Arndt & Rebecca E. Nordquist. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse
4
17
.
. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse
1
17
.
Liliana Menalled & Daniela Brunner. (2014) Animal models of Huntington's disease for translation to the clinic: Best practices. Movement Disorders 29:11, pages 1375-1390.
Crossref
Crossref
C A Federico, B Carlisle, J Kimmelman & D A Fergusson. (2014) Late, never or non-existent: the inaccessibility of preclinical evidence for new drugs. British Journal of Pharmacology 171:18, pages 4247-4254.
Crossref
Crossref
Michele Simonato, Amy R Brooks-Kayal, Jerome EngelJrJr, Aristea S Galanopoulou, Frances E Jensen, Solomon L Moshé, Terence J O'Brien, Asla Pitkanen, Karen S Wilcox & Jacqueline A French. (2014) The challenge and promise of anti-epileptic therapy development in animal models. The Lancet Neurology 13:9, pages 949-960.
Crossref
Crossref
Kieren Egan & Malcolm Macleod. (2014) Two decades testing interventions in transgenic mouse models of Alzheimer's disease: designing and interpreting studies for clinical trial success. Clinical Investigation 4:8, pages 693-704.
Crossref
Crossref
Matthew C Evans, Sébastien Serres, Alexandre A Khrapitchev, Helen B Stolp, Daniel C Anthony, Kevin Talbot, Martin R Turner & Nicola R Sibson. (2014)
T
2
-Weighted MRI Detects Presymptomatic Pathology in the SOD1 Mouse Model of ALS
. Journal of Cerebral Blood Flow & Metabolism 34:5, pages 785-793.
Crossref
Crossref
Barış Genç & P. Hande Özdinler. (2014) Moving forward in clinical trials for ALS: motor neurons lead the way please. Drug Discovery Today 19:4, pages 441-449.
Crossref
Crossref
Dieter Schmidt, Daniel Friedman & Marc A. Dichter. (2014) Anti-epileptogenic Clinical Trial Designs in Epilepsy: Issues and Options. Neurotherapeutics 11:2, pages 401-411.
Crossref
Crossref
Steve Perrin. (2014) Preclinical research: Make mouse studies work. Nature 507:7493, pages 423-425.
Crossref
Crossref
Marco Peviani, Eleonora Salvaneschi, Leonardo Bontempi, Alessandro Petese, Antonio Manzo, Daniela Rossi, Mario Salmona, Simona Collina, Paolo Bigini & Daniela Curti. (2014) Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiology of Disease 62, pages 218-232.
Crossref
Crossref
Robyn A. Grant, Paul S. Sharp, Aneurin J. Kennerley, Jason Berwick, Andrew Grierson, Tennore Ramesh & Tony J. Prescott. (2014) Abnormalities in whisking behaviour are associated with lesions in brain stem nuclei in a mouse model of amyotrophic lateral sclerosis. Behavioural Brain Research 259, pages 274-283.
Crossref
Crossref
Kazunori Tanaka, Takuya Kanno, Yoshiko Yanagisawa, Kaori Yasutake, Satoshi Inoue, Noriaki Hirayama & Joh-E Ikeda. (2014) A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model. PLoS ONE 9:1, pages e87728.
Crossref
Crossref
Savina ApolloniSusanna AmadioChiara ParisiAlessandra MatteucciRosa Luisa PotenzaMonica ArmidaPatrizia PopoliNadia D'Ambrosi & Cinzia Volonté. (2014) Spinal cord pathology is ameliorated by P2X7 antagonism in SOD1-G93A mouse model of amyotrophic lateral sclerosis. Disease Models & Mechanisms.
Crossref
Crossref
Susanna Amadio, Chiara Parisi, Cinzia Montilli, Alberto Savio Carrubba, Savina Apolloni & Cinzia Volonté. (2014)
P2Y
12
Receptor on the Verge of a Neuroinflammatory Breakdown
. Mediators of Inflammation 2014, pages 1-15.
Crossref
Crossref
Displaying 200 of 253 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list